Asset Allocation

As of January 31, 2026.
Type % Net
Cash 0.89%
Stock 78.75%
Bond 11.22%
Convertible 0.00%
Preferred 7.31%
Other 1.83%
View Asset Allocation
Start Trial

Market Capitalization

As of January 31, 2026
Large 94.34%
Mid 4.79%
Small 0.87%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.34%    % Emerging Markets: 0.07%    % Unidentified Markets: 0.59%

Americas 96.85%
95.01%
Canada 81.20%
United States 13.81%
1.84%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 2.34%
United Kingdom 0.87%
1.48%
Denmark 0.00%
France 0.05%
Germany 0.54%
Ireland 0.84%
Netherlands 0.00%
Spain 0.03%
Switzerland 0.00%
0.00%
0.00%
Greater Asia 0.22%
Japan 0.00%
0.21%
Australia 0.21%
0.00%
Singapore 0.00%
0.00%
Unidentified Region 0.59%

Bond Credit Quality Exposure

AAA 26.95%
AA 10.15%
A 19.52%
BBB 20.55%
BB 6.18%
B 1.78%
Below B 0.16%
    CCC 0.16%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.22%
Not Available 14.50%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
61.16%
Materials
1.52%
Consumer Discretionary
5.18%
Financials
54.46%
Real Estate
0.00%
Sensitive
30.07%
Communication Services
1.02%
Energy
10.47%
Industrials
14.65%
Information Technology
3.94%
Defensive
8.38%
Consumer Staples
2.67%
Health Care
2.24%
Utilities
3.48%
Not Classified
0.38%
Non Classified Equity
0.25%
Not Classified - Non Equity
0.13%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 27.83%
Corporate 44.67%
Securitized 0.40%
Municipal 15.70%
Other 11.41%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.47%
Less than 1 Year
1.47%
Intermediate
63.96%
1 to 3 Years
4.93%
3 to 5 Years
11.76%
5 to 10 Years
47.27%
Long Term
33.10%
10 to 20 Years
9.01%
20 to 30 Years
15.22%
Over 30 Years
8.87%
Other
1.47%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial